Recent developments in the treatment of metastatic colorectal cancer

Abstract

Over the past decade there have been significant advances in the molecular characterization of colorectal cancer (CRC) that are driving treatment decisions. Expanded RAS testing beyond KRAS exon 2 was established as crucial for identifying patients who will respond to anti-epidermal growth factor receptor (EGFR) therapies and low-frequency mutations in RAS… (More)
DOI: 10.1177/1758834017714997

Topics

4 Figures and Tables

Cite this paper

@inproceedings{Loree2017RecentDI, title={Recent developments in the treatment of metastatic colorectal cancer}, author={Jonathan M. Loree and Scott Kopetz}, booktitle={Therapeutic advances in medical oncology}, year={2017} }